EUVIMEDEUVIMED entdecken
VergleichsstudieRandomisierte kontrollierte Studie

Comparison of outcomes of azathioprine, leflunomide and allergen avoidance in patients with patch test-positive pigmented contact dermatitis: a randomized comparative study

Surabhi Sinha, Kabir Sardana, Sanjeet Panesar, Konchok Dorjay, Purnima Malhotra

Clinical and Experimental Dermatology · 2024

DOI: 10.1093/ced/llad378 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Clinical and Experimental Dermatology, 2024. Verfasst von Surabhi Sinha und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Lady Hardinge Medical College and Associated Hospital, New Delhi, India. Hauptthemen laut MEDLINE: Dermatitis, Allergic Contact, Melanosis. Die Arbeit nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pigmented contact dermatitis (PCD) is a noneczematous form of allergic contact dermatitis characterized by dermal hyperpigmentation. Allergen avoidance is the cornerstone of therapy, but it is difficult to achieve. The use of immunosuppressives seems rational, but data are lacking.

Objectives

To compare outcomes with azathioprine (AZA), leflunomide and allergen avoidance (AA) in patients with PCD.

Methods

A comparative study was conducted on 28 patients with patch test-positive PCD who were randomly allocated to one of three treatment groups: AZA 2 mg kg–1 daily for 24 weeks + AA (n = 10); leflunomide (LEF) 20 mg daily for 24 weeks + ­AA (n = 8); AA alone (n = 10). Patients were followed up for an additional 24 weeks. The Dermal Pigmentation Area and Severity Index (DPASI) score and Hindi Melasma Quality of Life scale (MELASQOL) were used to assess hyperpigmentation and quality of life (QoL). respectively.

Results

Hair colorants (n = 12) and paraphenylenediamine (n = 8) were the most common allergens. Mean (SD) DPASI score decreased from 30.97 (3.69), 32.35 (3.90) and 31.86 (3.47) to 13.78 (4.25), 21.67 (2.99) and 20.64 (3.82) at 48 weeks in the three groups, respectively (P < 0.001); the maximum percentage decline was seen with AZA (56%). Mean (SD) MELASQOL score was reduced in the three treatment groups from 48.0 (6.46), 46.75 (3.69) and 46.6 (4.65) to 19.6 (6.98), 24.5 (5.80) and 24.0 (5.49), respectively, at 48 weeks (P < 0.001). Reductions in DPASI and Hindi MELASQOL scores were significantly correlated. The most frequent adverse event was transaminitis in both the AZA and LEF groups.

Conclusions

Patients on AZA achieved a statistically significantly greater reduction in DPASI and MELASQOL score; therefore, AZA may fulfil an unmet need in PCD treatment. An objective reduction in hyperpigmentation was paralleled by an improvement in QoL score, reiterating the need for active management of this disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, Allergic ContactMelanosisHumansAllergensAzathioprineLeflunomidePatch TestsQuality of Life

Substanzen

AllergensAzathioprineLeflunomide

Autor:innen und Institutionen

  • Department of Dermatology, Lady Hardinge Medical College and Associated Hospital, New Delhi, India.
  • Departments of Dermatology.
  • Community Medicine.
  • Derma Clinic, Leh, Ladakh, India.
  • Pathology, ABVIMS & Dr. RML Hospital, New Delhi, India.

Zitieren

APA

Sinha, S., Sardana, K., Panesar, S., Dorjay, K., & Malhotra, P. (2024). Comparison of outcomes of azathioprine, leflunomide and allergen avoidance in patients with patch test-positive pigmented contact dermatitis: a randomized comparative study. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llad378

Vancouver

Sinha S, Sardana K, Panesar S, Dorjay K, Malhotra P. Comparison of outcomes of azathioprine, leflunomide and allergen avoidance in patients with patch test-positive pigmented contact dermatitis: a randomized comparative study. Clinical and Experimental Dermatology. 2024. doi:10.1093/ced/llad378

BibTeX
@article{Sinha2024,
  author = {Sinha, Surabhi and Sardana, Kabir and Panesar, Sanjeet and Dorjay, Konchok and Malhotra, Purnima},
  title = {Comparison of outcomes of azathioprine, leflunomide and allergen avoidance in patients with patch test-positive pigmented contact dermatitis: a randomized comparative study},
  journal = {Clinical and Experimental Dermatology},
  year = {2024},
  doi = {10.1093/ced/llad378}
}
Kostenlos starten →